Richard LeFave - Amdocs Independent Director

DOX
 Stock
  

USD 83.04  1.41  1.67%   

  Director
Mr. Richard T.C. LeFave is Independent Director of Amdocs Limited., since November 2011. Since 2008, Mr. LeFave was a Principal at DL Partners, LLC, an information technology consulting firm. Mr. LeFave served as Chief Information Officer for Nextel Communications, a telecommunications company, from 1999 until its merger with Sprint Corporationrationration in 2005, after which he served as Chief Information Officer for Sprint Nextel Corporationrationration until 2008. From 1995 to 1999, Mr. LeFave served as Chief Information Officer for Southern New England Telephone Company, a provider of communications products and services. We believe Mr. LeFaves qualifications to sit on our board include his extensive experience and leadership in the information technology and telecommunications industry.
Age: 64  Director Since 2011      
(44) 1481 728444  www.amdocs.com

Amdocs Management Efficiency

Amdocs Limited has Return on Asset of 5.76 % which means that on every $100 spent on asset, it made $5.76 of profit. This is considered to be average in the sector. In the same way, it shows return on shareholders equity (ROE) of 14.03 %, implying that it generated $14.03 on every 100 dollars invested. Amdocs management efficiency ratios could be used to measure how well the company manages its routine affairs as well as how well it operates its assets and liabilities. Return on Invested Capital is likely to rise to 0.44 in 2022, whereas Return on Investment is likely to drop 12.42 in 2022. Amdocs Tax Assets are fairly stable at the moment as compared to the past year. Amdocs reported Tax Assets of 135.66 Million in 2021. Revenue to Assets is likely to rise to 0.60 in 2022, whereas Total Assets are likely to drop slightly above 7 B in 2022.
The company has 879.12 M in debt with debt to equity (D/E) ratio of 0.25, which may show that the company is not taking advantage of profits from borrowing. Amdocs Limited has a current ratio of 1.47, which is typical for the industry and considered as normal. Debt can assist Amdocs until it has trouble settling it off, either with new capital or with free cash flow. So, Amdocs' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Amdocs Limited sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Amdocs to invest in growth at high rates of return. When we think about Amdocs' use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing few of many executives

DIRECTOR Since

William KaneThe Travelers Companies
2012
Frederick WaddellInternational Business Machines
2017
Andrew LiverisInternational Business Machines
2010
Roxanne AustinVerizon Communications
2020
Pamela CraigMerck Company
2015
Alan BellerThe Travelers Companies
2007
Craig ThompsonMerck Company
2008
John DasburgThe Travelers Companies
2017
Kathy WardenMerck Company
2020
Donald ShepardThe Travelers Companies
2009
Anne MulcahyJohnson Johnson
2012
Thomas HodgsonThe Travelers Companies
1997
Todd SchermerhornThe Travelers Companies
2016
Martha KeethVerizon Communications
2019
Michael EskewInternational Business Machines
2005
Wesley BushCisco Systems
2019
Karen ParkhillAmerican Express
2020
KarlLudwig KleyVerizon Communications
2015
William BrodyInternational Business Machines
2007
Arun SarinCisco Systems
2009
Sidney TaurelInternational Business Machines
2001
Amdocs Limited, through its subsidiaries, provides software and services worldwide. Amdocs Limited was founded in 1988 and is headquartered in Chesterfield, Missouri. Amdocs operates under SoftwareInfrastructure classification in the United States and is traded on NASDAQ Exchange. It employs 29000 people. Amdocs Limited (DOX) is traded on NASDAQ Exchange in USA. It is located in Hirzel House, Smith Street, St. Peter Port, Island of Guernsey GY1 2NG, United Kingdom and employs 29,000 people. Amdocs is listed under Business Services category by Fama And French industry classification.

Amdocs Limited Leadership Team

Elected by the shareholders, the Amdocs' board of directors comprises two types of representatives: Amdocs inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Amdocs. The board's role is to monitor Amdocs' management team and ensure that shareholders' interests are well served. Amdocs' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Amdocs' outside directors are responsible for providing unbiased perspectives on the board's policies.
Richard LeFave, Independent Director
Matthew Smith, Corporate Secretary
John MacDonald, Director
Adrian Gardner, Independent Director
Tamar RapaportDagim, Senior Vice President and CFO of Amdocs Management Limited
Zohar Zisapel, Independent Director
Simon Olswang, Independent Director
Anshoo Gaur, Division President of Amdocs Devel. Center India Pvt Ltd
Elizabeth McDermon, Secretary and VP of Corporate Strategy of Amdocs Inc.
Giora Yaron, Director
Shuky Sheffer, Senior Vice President and President of Customer Business Group, Amdocs Management Limited
John McLennan, Independent Director
Robert Minicucci, Independent Chairman of the Board
Matt Smith, IR Contact Officer
Clayton Christensen, Director
Julian Brodsky, Independent Director
James Kahan, Independent Director
Eli Gelman, Director, Member of Technology and Innovation Committee, CEO of Amdocs Management Limited and President of Amdocs Management Limited
Rajat Raheja, Division President Amdocs Development Center India Pvt. Ltd

Amdocs Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Amdocs a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Amdocs Investors Sentiment

The influence of Amdocs' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Amdocs. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.
Investor biases related to Amdocs' public news can be used to forecast risks associated with investment in Amdocs. The trend in average sentiment can be used to explain how an investor holding Amdocs can time the market purely based on public headlines and social activities around Amdocs Limited. Please note that most equiteis that are difficult to arbitrage are affected by market sentiment the most.
Amdocs' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Amdocs' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Amdocs' news discussions. The higher the estimate score, the more favorable is the investor's outlook on Amdocs.

Amdocs Implied Volatility

    
  41.72  
Amdocs' implied volatility exposes the market's sentiment of Amdocs Limited stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Amdocs' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Amdocs stock will not fluctuate a lot when Amdocs' options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Amdocs in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Amdocs' short interest history, or implied volatility extrapolated from Amdocs options trading.

Current Sentiment - DOX

Amdocs Limited Investor Sentiment

Greater number of Macroaxis users are currently bullish on Amdocs Limited. What is your sentiment towards investing in Amdocs Limited? Are you bullish or bearish?
Bullish
Bearish
98% Bullish
2% Bearish

Pair Trading with Amdocs

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Amdocs position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Amdocs will appreciate offsetting losses from the drop in the long position's value.

Amdocs Pair Correlation

Correlation Analysis For Direct Indexing and Tax-loss Harvesting

The ability to find closely correlated positions to Amdocs could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Amdocs when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Amdocs - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Amdocs Limited to buy it.
The correlation of Amdocs is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Amdocs moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Amdocs Limited moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Amdocs can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Continue to Investing Opportunities. Note that the Amdocs Limited information on this page should be used as a complementary analysis to other Amdocs' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.

Complementary Tools for Amdocs Stock analysis

When running Amdocs Limited price analysis, check to measure Amdocs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amdocs is operating at the current time. Most of Amdocs' value examination focuses on studying past and present price action to predict the probability of Amdocs' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Amdocs' price. Additionally, you may evaluate how the addition of Amdocs to your portfolios can decrease your overall portfolio volatility.
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Go
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Go
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Go
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Go
Is Amdocs' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Amdocs. If investors know Amdocs will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Amdocs listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
0.41
Market Capitalization
10.2 B
Quarterly Revenue Growth YOY
0.092
Return On Assets
0.0601
Return On Equity
0.16
The market value of Amdocs Limited is measured differently than its book value, which is the value of Amdocs that is recorded on the company's balance sheet. Investors also form their own opinion of Amdocs' value that differs from its market value or its book value, called intrinsic value, which is Amdocs' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Amdocs' market value can be influenced by many factors that don't directly affect Amdocs' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Amdocs' value and its price as these two are different measures arrived at by different means. Investors typically determine Amdocs value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Amdocs' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.